Skip to content

Medico-economic Impacts of NeLLY Service for Not on Dialysis Severe Chronic Kidney Disease

Multicentre Trial, With Stepped Wedge Randomized Controled Clusters, on Medico-economic Impacts of NeLLY Service for Not on Dialysis Severe Chronic Kidney Disease

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03348839
Enrollment
600
Registered
2017-11-21
Start date
2018-03-31
Completion date
2021-06-30
Last updated
2018-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease stage4, Kidney Diseases

Keywords

telemedicine, telemonitoring, educational therapy

Brief summary

This medico-economic research project (PRME) aim to analyse NeLLY service efficiency for not on dialysis severe chronic kidney disease (DFG \< 30ml/mn) patients care. NeLLY is a service that includes telemonitoring, educational therapy and support for patients with severe chronic kidney disease.

Detailed description

NeLLY study is a multicentre trial, with stepped wedge randomized controled clusters. 2 strategies will be compared: usual patients follow-up and NeLLY service. The primary endpoint of the study is incremental cost-effectiveness ratio. This 3 years study will include 600 French patients. NeLLY service, offering telemonitoring, educational therapy and support to patients with severe chronic kidney disease, is based on an app, both for patients and health professionals, named Ap'Telecare (@TMM).

Interventions

DEVICENeLLY service

Telesurveillance and therapeutic support

Sponsors

Hospices Civils de Lyon
CollaboratorOTHER
Calydial
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Masking description

no one

Intervention model description

Multicentre study, in randomized mastered clusters, in stepped wedge

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patient with chronic kidney disease stage 4 * patient with at least 1 cardiovascular comorbidity and / or diabetes * patient with internet connexion from home * patient having given his express consent

Exclusion criteria

* dialysed patient * refusal of patient to take part in the research * impairment of vital prognosis within a short period * patient expecting a transplant from a living donor within 6 months

Design outcomes

Primary

MeasureTime frameDescription
Incremental cost-effectiveness ratioData collection all along the study: 3 yearsThe primary endpoint of the study is incremental cost-effectiveness ratio comparing 2 strategies : usual patients follow-up and NeLLY service

Secondary

MeasureTime frameDescription
Evaluation of quality of life related to each strategyevery 4 months, all along the study: 3 yearsSpecific questionnaire analysing patient's mobility, autonomy, pain and discomfort, anxiety and depression (patient's answer can be yes or no)
Evaluation of the financial impact of NeLLY service implementation in FranceData collection every 4 months at least, all along the study: 3 yearsAll medical expenses will be collected in the case report form
Evaluation of costs related to each strategyData collection every 4 months at least, all along the study: 3 yearsAll medical expenses will be collected in the case report form
Evaluation of NeLLY service impacts on dialysis and transplantData collection all along the study: 3 yearsThe question is: does NeLLY delay resorting to dialysis, avoid emergency dialysis, encourage transplant
Evaluation of NeLLY service impacts on compliance of patients4 times during the study: 3 yearsSpecific questionnaire: Did the patient forget this morning to take medication? Since his last consultation, did the patient already miss any medication at home? Is the patient sometimes late to take medication? Did the patient already forget medication because of a lapse of memory? Did the patient already miss to take a medication because the patient think it can do more harm than good? Do the patient believe having too many medication to take? Patient's answer can be yes or no.
Evaluation of clinical impact of NeLLY serviceData collection all along the study: 3 yearsThe question is: does NeLLY reduce hospitalisation, slow chronic kidney disease evolution, increase blood pressure control. Data will be collected during usual nephrology consultations.

Countries

France

Contacts

Primary ContactCAILLETTE BEAUDOIN Agnès
direction@calydial.org428873800
Backup ContactCAMARROQUE Anne-Laure
anne-laure.camarroque@calydial.org428873851

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026